Skip to main content

Table 2 Cox proportional hazard ratios (HR) for all-cause mortality

From: Association between the ROX index and mortality in patients with acute hypoxemic respiratory failure: a retrospective cohort study

Categories

Deaths (%)

Unadjusted model

Adjusted model

HR (95% CI)

P-value

HR (95% CI)

P-value

28-day mortality

Q1 (N = 454)

157 (34.6%)

reference

 

reference

 

Q2 (N = 453)

127 (28%)

0.754 (0.597–0.953)

0.018

0.749 (0.590–0.950)

0.017

Q3 (N = 451)

124 (27.5%)

0.735 (0.581–0.930)

0.010

0.711 (0.558–0.906)

0.006

Q4 (N = 455)

105 (23.1%)

0.595 (0.465–0.762)

< 0.001

0.641 (0.495–0.830)

< 0.001

3-month mortality

Q1 (N = 454)

195 (43%)

reference

 

reference

 

Q2 (N = 453)

153 (33.8%)

0.726 (0.587–0.897)

0.003

0.705 (0.568–0.874)

0.001

Q3 (N = 451)

156 (34.6%)

0.739 (0.599–0.912)

0.005

0.690 (0.555–0.857)

< 0.001

Q4 (N = 455)

136 (29.9%)

0.611 (0.491–0.760)

< 0.001

0.640 (0.509–0.804)

< 0.001

6-month mortality

Q1 (N = 454)

205 (45.2%)

reference

 

reference

 

Q2 (N = 453)

174 (38.4%)

0.782 (0.639–0.957)

0.017

0.753 (0.613–0.925)

0.007

Q3 (N = 451)

175 (38.8%)

0.786 (0.642–0.962)

0.019

0.723 (0.587–0.890)

0.002

Q4 (N = 455)

151 (33.2%)

0.641 (0.519–0.791)

< 0.001

0.662 (0.531–0.824)

< 0.001

1-year mortality

Q1 (N = 454)

217 (47.8%)

reference

 

reference

 

Q2 (N = 453)

198 (43.7%)

0.840 (0.693–1.018)

0.076

0.801 (0.658–0.974)

0.026

Q3 (N = 451)

185 (41%)

0.783 (0.644–0.953)

0.015

0.710 (0.580–0.869)

< 0.001

Q4 (N = 455)

175 (38.5%)

0.699 (0.573–0.853)

< 0.001

0.708 (0.575–0.872)

0.001

  1. Q1: (ROX ≤ 5.89), Q2: (5.89 < ROX ≤ 8.28), Q3: (8.28 < ROX ≤ 11.24), Q4: (ROX > 11.24)
  2. HR: hazard ratio; CI: confidence interval;
  3. Adjusted model: adjusted for age, gender, race, Charlson comorbidity index, cerebrovascular disease, malignant cancer, severe liver disease, white blood cell, potassium, sodium, calcium, glucose, albumin, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, creatinine, international normalized ratio, prothrombin time, partial thromboplastin time, high flow nasal cannula, invasive vent